August 2022
272-2022 Staff contacts
273-2022 Off framework usage 21-22
274-2022 Nivolumab
275-2022 Facilities Management
276-2022 Spend - foreign interpreters
277-2022 Guardian of Safe Working
278-2022 Interventional Radiology Procedures
279-2022 As above
280-2022 Microsoft O365
281-2022 Maternity Unit Complaints
282-2022 Settlement Agreements
283-2022 Sterile services
287-2022 Funding
288-2022 Clinical Director Info
289-2022 Hospital initiated cancellation of appointments
290-2022 Neuroimaging technology and epilepsy patients
291-2022 EPR
292-2022 Waiting lists, postal services, patient portal, communication services, points of contact
293-2022 ACR Laboratory Device
294-2022 Various
295-2022 Robotic Process Automation
296-2022 Contact centre, CRM and AI & Automation
297-2022 Prescribed PrEP medication
298-2022 Trust outsource - albumin:creatinine ratio analysis
299-2022 Agency usage for radiography
300-2022 International recruitment
301-2022 Maternity services
302-2022 Scanners/MRI
303-2022 Windows 11 approved processors
304-2022 Community Digital Centre
305-2022 Oncotype use for breast cancer
306-2022 EUS-FNB procedures
307-2022 Offensive waste and clinical waste
308-2022 Diabetes
309-2022 Mobile phone and data contracts
310-2022 Immune thrombocytopenia
311-2022 Audit minutes April-July 2022
312-2022 Treatment myelofibrosis
313-2022 Orthopaedic consultants
314-2022 Melanoma Patients
315-2022 Telephony and storage
316-2022 Contractual provision of endoscopy staff and facilities
317-2022 As above
318-2022 Trust information
319-2022 CAM services
320-2022 Organisation structure for comms dept
321-2022 Treatment lung cancer
322-2022 Neonatal sepsis
323-2022 Operating theatres
324-2022 Sharps waste
326-2022 Medical devcies
327-2022 Metastatic breast cancer treatment on behalf of Novartis
